Katharina Hellwig

514 total citations
18 papers, 340 citations indexed

About

Katharina Hellwig is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Katharina Hellwig has authored 18 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Katharina Hellwig's work include Respiratory Support and Mechanisms (6 papers), Sepsis Diagnosis and Treatment (4 papers) and Neonatal Respiratory Health Research (3 papers). Katharina Hellwig is often cited by papers focused on Respiratory Support and Mechanisms (6 papers), Sepsis Diagnosis and Treatment (4 papers) and Neonatal Respiratory Health Research (3 papers). Katharina Hellwig collaborates with scholars based in Germany and United States. Katharina Hellwig's co-authors include Norbert Suttorp, Stefan Hippenstiel, Martin Witzenrath, Thomas Tschernig, Holger C. Müller, Holger Müller-Redetzky, Birgitt Gutbier, Martin Witzenrath, Achim D. Gruber and Jan Naujoks and has published in prestigious journals such as PLoS ONE, Anesthesiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Katharina Hellwig

16 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharina Hellwig Germany 8 121 120 120 77 37 18 340
R. Cagnina United States 9 160 1.3× 74 0.6× 135 1.1× 53 0.7× 15 0.4× 18 501
Catalina Crespı́ Spain 14 80 0.7× 155 1.3× 173 1.4× 78 1.0× 10 0.3× 28 473
Dale R. Tabor United States 10 109 0.9× 94 0.8× 190 1.6× 57 0.7× 12 0.3× 27 380
Luis Vizcaíno Spain 9 62 0.5× 77 0.6× 128 1.1× 91 1.2× 5 0.1× 13 390
Osamu Narumoto Japan 10 77 0.6× 60 0.5× 40 0.3× 144 1.9× 12 0.3× 21 318
K C Flint United Kingdom 12 253 2.1× 99 0.8× 293 2.4× 44 0.6× 25 0.7× 24 714
M. Radermecker Belgium 13 143 1.2× 70 0.6× 116 1.0× 24 0.3× 10 0.3× 39 418
Samira Salek‐Ardakani United Kingdom 7 91 0.8× 103 0.9× 174 1.4× 116 1.5× 6 0.2× 9 463
Yuxiong Guo China 10 54 0.4× 56 0.5× 25 0.2× 66 0.9× 26 0.7× 31 252
Tatsuo Oyake Japan 10 56 0.5× 91 0.8× 32 0.3× 80 1.0× 60 1.6× 34 338

Countries citing papers authored by Katharina Hellwig

Since Specialization
Citations

This map shows the geographic impact of Katharina Hellwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Hellwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Hellwig more than expected).

Fields of papers citing papers by Katharina Hellwig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Hellwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Hellwig. The network helps show where Katharina Hellwig may publish in the future.

Co-authorship network of co-authors of Katharina Hellwig

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Hellwig. A scholar is included among the top collaborators of Katharina Hellwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Hellwig. Katharina Hellwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gutbier, Birgitt, Geraldine Nouailles, Diana Fatykhova, et al.. (2025). Diabetes impairs IFNγ-dependent antibacterial defense in the lungs. Mucosal Immunology. 18(2). 431–440.
2.
Fatykhova, Diana, Karen Hoffmann, Mirjana Kessler, et al.. (2022). State-of-the-art analytical methods of viral infections in human lung organoids. PLoS ONE. 17(12). e0276115–e0276115. 2 indexed citations
3.
Müller-Redetzky, Holger, Sandra-Maria Wienhold, Birgitt Gutbier, et al.. (2020). Neutralizing Complement C5a Protects Mice with Pneumococcal Pulmonary Sepsis. Anesthesiology. 132(4). 795–807. 22 indexed citations
4.
Müller-Redetzky, Holger, Katharina Hellwig, Sandra-Maria Wienhold, et al.. (2015). Increasing the inspiratory time and I:E ratio during mechanical ventilation aggravates ventilator-induced lung injury in mice. Critical Care. 19(1). 23–23. 36 indexed citations
5.
Hellwig, Katharina, Mario Tönnies, Paul Schneider, et al.. (2015). IVA induced IFNs facilitate development of secondary pneumococcal pneumonia in human lung tissue. Pneumologie. 69(4). 1 indexed citations
6.
Müller-Redetzky, Holger, Sandra-Maria Wienhold, Johanna Berg, et al.. (2014). Moxifloxacin is not anti-inflammatory in experimental pneumococcal pneumonia. Journal of Antimicrobial Chemotherapy. 70(3). 830–840. 12 indexed citations
7.
Müller-Redetzky, Holger, Katharina Hellwig, Sandra-Maria Wienhold, et al.. (2014). Increasing the inspiratory time and I:E ratio during mechanical ventilation aggravates Ventilator-induced lung injury in mice. Pneumologie. 68(S 01). 1 indexed citations
8.
Tschernig, Thomas, Sandra-Maria Wienhold, Katharina Hellwig, et al.. (2014). Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis. Pneumologie. 68(2). 4 indexed citations
9.
Müller-Redetzky, Holger, Katharina Hellwig, Wolfgang Kummer, et al.. (2014). Mechanical ventilation drives pneumococcal pneumonia into lung injury and sepsis in mice: protection by adrenomedullin. Critical Care. 18(2). R73–R73. 57 indexed citations
10.
Müller-Redetzky, Holger, Wolfgang Kummer, Uwe Pfeil, et al.. (2012). Intermedin Stabilized Endothelial Barrier Function and Attenuated Ventilator-induced Lung Injury in Mice. PLoS ONE. 7(5). e35832–e35832. 23 indexed citations
11.
Lippmann, Juliane, Holger C. Müller, Jan Naujoks, et al.. (2011). Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice. Cellular Microbiology. 13(11). 1668–1682. 70 indexed citations
12.
Müller, Holger C., Andreas C. Hocke, Katharina Hellwig, et al.. (2011). The Sphingosine-1 Phosphate receptor agonist FTY720 dose dependently affected endothelial integrity in vitro and aggravated ventilator-induced lung injury in mice. Pulmonary Pharmacology & Therapeutics. 24(4). 377–385. 41 indexed citations
13.
Müller, Holger C., Wolfgang Kummer, Uwe Pfeil, et al.. (2011). Intermedin Stabilized Endothelial Barrier Function And Attenuated Ventilator-Induced Lung Injury In Mice. A1952–A1952. 1 indexed citations
14.
Müller, Holger C., Katharina Hellwig, Simone Rosseau, et al.. (2010). Simvastatin attenuates ventilator-induced lung injury in mice. Critical Care. 14(4). R143–R143. 59 indexed citations
15.
Witzenrath, Martin, Katharina Hellwig, Thomas Tschernig, et al.. (2010). Simvastatin attenuates ventilator-induced lung injury in mice. Pneumologie. 64(1). 3 indexed citations
16.
Müller, Holger C., Katharina Hellwig, Thomas Tschernig, et al.. (2010). Simvastatin Attenuates Ventilator-induced Lung Injury In Mice. A1683–A1683. 1 indexed citations
17.
Hellwig, Katharina, et al.. (2006). Nobelpreis für schweigende Gene. Biologie in unserer Zeit. 36(6). 352–353.
18.
Büttner, Thomas, Katharina Hellwig, Tim Müller, & W. Kühn. (1998). Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.. PubMed. 21(1). 48–51. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026